Cargando…

Recent Progress and Advances of Multi-Stimuli-Responsive Dendrimers in Drug Delivery for Cancer Treatment

Despite the fact that nanocarriers as drug delivery systems overcome the limitation of chemotherapy, the leakage of encapsulated drugs during the delivery process to the target site can still cause toxic effects to healthy cells in other tissues and organs in the body. Controlling drug release at th...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Ngoc Thuy Trang, Nguyen, Thi Nhu Quynh, Cao, Van Du, Hoang, Duc Thuan, Ngo, Van Cuong, Hoang Thi, Thai Thanh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920789/
https://www.ncbi.nlm.nih.gov/pubmed/31717376
http://dx.doi.org/10.3390/pharmaceutics11110591
_version_ 1783481013143339008
author Le, Ngoc Thuy Trang
Nguyen, Thi Nhu Quynh
Cao, Van Du
Hoang, Duc Thuan
Ngo, Van Cuong
Hoang Thi, Thai Thanh
author_facet Le, Ngoc Thuy Trang
Nguyen, Thi Nhu Quynh
Cao, Van Du
Hoang, Duc Thuan
Ngo, Van Cuong
Hoang Thi, Thai Thanh
author_sort Le, Ngoc Thuy Trang
collection PubMed
description Despite the fact that nanocarriers as drug delivery systems overcome the limitation of chemotherapy, the leakage of encapsulated drugs during the delivery process to the target site can still cause toxic effects to healthy cells in other tissues and organs in the body. Controlling drug release at the target site, responding to stimuli that originated from internal changes within the body, as well as stimuli manipulated by external sources has recently received significant attention. Owning to the spherical shape and porous structure, dendrimer is utilized as a material for drug delivery. Moreover, the surface region of dendrimer has various moieties facilitating the surface functionalization to develop the desired material. Therefore, multi-stimuli-responsive dendrimers or ‘smart’ dendrimers that respond to more than two stimuli will be an inspired attempt to achieve the site-specific release and reduce as much as possible the side effects of the drug. The aim of this review was to delve much deeper into the recent progress of multi-stimuli-responsive dendrimers in the delivery of anticancer drugs in addition to the major potential challenges.
format Online
Article
Text
id pubmed-6920789
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69207892019-12-24 Recent Progress and Advances of Multi-Stimuli-Responsive Dendrimers in Drug Delivery for Cancer Treatment Le, Ngoc Thuy Trang Nguyen, Thi Nhu Quynh Cao, Van Du Hoang, Duc Thuan Ngo, Van Cuong Hoang Thi, Thai Thanh Pharmaceutics Review Despite the fact that nanocarriers as drug delivery systems overcome the limitation of chemotherapy, the leakage of encapsulated drugs during the delivery process to the target site can still cause toxic effects to healthy cells in other tissues and organs in the body. Controlling drug release at the target site, responding to stimuli that originated from internal changes within the body, as well as stimuli manipulated by external sources has recently received significant attention. Owning to the spherical shape and porous structure, dendrimer is utilized as a material for drug delivery. Moreover, the surface region of dendrimer has various moieties facilitating the surface functionalization to develop the desired material. Therefore, multi-stimuli-responsive dendrimers or ‘smart’ dendrimers that respond to more than two stimuli will be an inspired attempt to achieve the site-specific release and reduce as much as possible the side effects of the drug. The aim of this review was to delve much deeper into the recent progress of multi-stimuli-responsive dendrimers in the delivery of anticancer drugs in addition to the major potential challenges. MDPI 2019-11-08 /pmc/articles/PMC6920789/ /pubmed/31717376 http://dx.doi.org/10.3390/pharmaceutics11110591 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Le, Ngoc Thuy Trang
Nguyen, Thi Nhu Quynh
Cao, Van Du
Hoang, Duc Thuan
Ngo, Van Cuong
Hoang Thi, Thai Thanh
Recent Progress and Advances of Multi-Stimuli-Responsive Dendrimers in Drug Delivery for Cancer Treatment
title Recent Progress and Advances of Multi-Stimuli-Responsive Dendrimers in Drug Delivery for Cancer Treatment
title_full Recent Progress and Advances of Multi-Stimuli-Responsive Dendrimers in Drug Delivery for Cancer Treatment
title_fullStr Recent Progress and Advances of Multi-Stimuli-Responsive Dendrimers in Drug Delivery for Cancer Treatment
title_full_unstemmed Recent Progress and Advances of Multi-Stimuli-Responsive Dendrimers in Drug Delivery for Cancer Treatment
title_short Recent Progress and Advances of Multi-Stimuli-Responsive Dendrimers in Drug Delivery for Cancer Treatment
title_sort recent progress and advances of multi-stimuli-responsive dendrimers in drug delivery for cancer treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920789/
https://www.ncbi.nlm.nih.gov/pubmed/31717376
http://dx.doi.org/10.3390/pharmaceutics11110591
work_keys_str_mv AT lengocthuytrang recentprogressandadvancesofmultistimuliresponsivedendrimersindrugdeliveryforcancertreatment
AT nguyenthinhuquynh recentprogressandadvancesofmultistimuliresponsivedendrimersindrugdeliveryforcancertreatment
AT caovandu recentprogressandadvancesofmultistimuliresponsivedendrimersindrugdeliveryforcancertreatment
AT hoangducthuan recentprogressandadvancesofmultistimuliresponsivedendrimersindrugdeliveryforcancertreatment
AT ngovancuong recentprogressandadvancesofmultistimuliresponsivedendrimersindrugdeliveryforcancertreatment
AT hoangthithaithanh recentprogressandadvancesofmultistimuliresponsivedendrimersindrugdeliveryforcancertreatment